Thousands of people at higher risk of developing cancer due to inherited faulty genes will be regularly checked and tracked by the NHS thanks to a first-of-its-kind national genetics programme.
A groundbreaking gene editing treatment is being offered to patients with sickle cell disease from today.
London (Greater)PO6 (£54,267 - £57,402)
Maidenhead, Berkshire£50,602 - £55,120 per annum
London (Greater)PO6 (£54,267 - £57,402)
Maidenhead, Berkshire£50,602 - £55,120 per annum